Skip to content

Modification of the Triazole Substitution

Edwin Tse edited this page Mar 12, 2019 · 19 revisions

Modification of the Triazole Substitution

Attempts at lowering the lipophilicity of the compounds by replacing the triazole aryl substituent with a cyclo(hetero)aliphatic group, linked either by the heteroatom or otherwise (e.g. piperidine, tetrahydropyran, indoline or isoindoline) lowered the potency against PfNF54, as did an aniline substituent. A dimethylpyrazole substituent was also deleterious - note the comparison with MMV670944, which is potent.

One of the original inherited documents for Series 4 indicated that "heteroaryl" was not tolerated in this position, but the data did support this as a blanket conclusion. Pyridinyl was found in 2014 (file mirror) to be a poor substituent, though one inherited compound containing a substituted pyridine was active.

Where an aromatic ring has been used in this position, it appears that a para-OCF3 and -OCHF2 groups generate higher potency than -OCH3 (data from 2014, ELN entry, file mirror)

Sets of (undergraduate-derived) compounds were evaluated in 2015 and 2016 with variation in the phenyl ring attached to the triazole while holding the phenethyl ether pyrazine substituent constant, revealing a high level of dependence of potency on the substitution of the phenyl ring. Thus while a para-chloro substitution pattern (MMV663915) gave rise to high potency, the other isomers and the des-chloro compound (MMV689970) were not potent. Some (low) potency was observed when there was anything other than C-H in the para position; generally substituents in the meta and ortho positions were deleterious.

A selection of benzylic alcohols were synthesised containing different substitution on the triazole ring. Once again, a paraphenyl-OCHF2 group led to potency whereas interestingly, a phenyl substituent led to inactivity, 2-substituted pyridine displayed micromolar activity, again suggesting that substituted pyridines could be further explored. Both cyclic and acyclic aliphatic compounds were inactive.

Generally speaking CN and Cl are well tolerated in the para position of an aromatic ring attached to the triazole, leading to highly potent compounds.

Replacement of the phenyl ring with a bioisosteric para-substituted cubane (for improving the solubility) is not well tolerated

Background

What is OSM Series 4?

Aims, Concerns and Current Interest in Series 4

Sources of Data

Structure-Activity Relationships

Modification of Core Triazolopyrazine

Modification of Pyrazine Substitution Pattern

Modification of the Triazole Substitution

Pyrazine Side Chain Modifications - Ethers

Pyrazine Side Chain Modifications - Amides

Pyrazine Side Chain Modifications - Reversed Amides

Pyrazine Side Chain Modifications - Others

Metabolites

Biological Data Currently not Incorporated into the Main Wiki Sections

Physicochemical/Metabolic Parameters

Physicochem/metabolism/PK

Metabolism ID

Aldehyde Oxidase Assay

Stages and Efficacy

Liver Stage

Gametocyte Stage

In Vivo Efficacy

Potency vs. Resistant Strains

Other Observations

Mechanism of Action, Activity and Toxicity

Mechanism of Action: Possible PfATP4 Activity Deduced from Parasite Ion Regulation Assays

hERG Activity

Toxicity

Synthetic Chemistry

Synthetic Design

Synthesis of the Ether-Linked Series

Synthesis of the Amide-Linked Series

Synthesis of the Reverse Amide- Linked Series

Synthesis of Benzylic Functionalised Ether-Linked Series

Alternative Routes to the Triazolopyrazine Core

Triazolopyrazine telesubstitution

Biofunctionalisation

Late Stage Functionalisation

Fluoroalkene Isostere

Spectroscopy

Chirality, Relevant and Desirable Compounds

Chirality/Stereogenic Centres in This Series

Other Sources of Compounds Relevant to this Series

Desirable Compounds Not Yet Synthesised

Other Evaluations

Evaluations vs Other Organisms

Strings

Strings for Google

Clone this wiki locally